NTRS vs TGTX · P/E 18, rev $2.69B vs P/E 18, rev $240.3M
Northern Trust Corporation (NTRS) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported NTRS revenue for 2026-06-30 was $2.69B. Net income was $1.32B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
NTRS currently screens at market cap $32.02B and trailing P/E 18.1. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the NTRS and TGTX stock pages for the full models.
Not investment advice.